v3.26.3
SCHEDULE OF BRIAPRO RESTRICTED STOCK UNITS GRANTED (Details) - Restricted Stock Units (RSUs) [Member]
 12 Months Ended
Jul. 31, 2026
USD ($)
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of RSU's outstanding, beginning balance | shares
Aggregate intrinsic value, beginning balance | $
Number of RSU's outstanding, granted | shares 160,000 [1]
Aggregate intrinsic value, granted | $ $ 743,200 [1]
Number of RSU's outstanding, ending balance | shares 160,000
Aggregate intrinsic value, ending balance | $ $ 550,400
BriaPro Therapeutics Corp, [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of RSU's outstanding, beginning balance | shares 19,200
Aggregate intrinsic value, beginning balance | $ $ 700
Number of RSU's outstanding, granted | shares 7,189,000 [2]
Aggregate intrinsic value, granted | $ $ 181,930 [2]
Number of RSU's outstanding, ending balance | shares 7,208,200
Aggregate intrinsic value, ending balance | $ $ 182,630
[1] On September 24, 2025, the Company granted 40,000 RSUs to directors under the Omnibus Plan. On June 29, 2026, the Company granted an additional 120,000 RSUs to directors under the Omnibus Plan. The RSUs vest in full on the earlier of September 23, 2028 or the occurrence of a change of control, resignation, or dismissal without cause. The aggregate grant-date fair value of the RSUs granted during the year was $743,200.
[2] On April 1, 2026, BriaPro granted 7,189,000 RSUs to directors under the Omnibus Plan. These RSUs vest in full on April 1, 2027. The grant-date fair value of these RSUs was $181,930, based on a grant-date fair value of approximately $0.0253 per RSU.